827 related articles for article (PubMed ID: 28711318)
21. Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta-analysis of randomized controlled trials.
Kopterides P; Siempos II; Tsangaris I; Tsantes A; Armaganidis A
Crit Care Med; 2010 Nov; 38(11):2229-41. PubMed ID: 20729729
[TBL] [Abstract][Full Text] [Related]
22. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
Harrison M; Collins CD
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
[TBL] [Abstract][Full Text] [Related]
23. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial.
Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schroeder S
Crit Care; 2009; 13(3):R83. PubMed ID: 19493352
[TBL] [Abstract][Full Text] [Related]
24. Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation.
Hellyer TP; McAuley DF; Walsh TS; Anderson N; Conway Morris A; Singh S; Dark P; Roy AI; Perkins GD; McMullan R; Emerson LM; Blackwood B; Wright SE; Kefala K; O'Kane CM; Baudouin SV; Paterson RL; Rostron AJ; Agus A; Bannard-Smith J; Robin NM; Welters ID; Bassford C; Yates B; Spencer C; Laha SK; Hulme J; Bonner S; Linnett V; Sonksen J; Van Den Broeck T; Boschman G; Keenan DJ; Scott J; Allen AJ; Phair G; Parker J; Bowett SA; Simpson AJ
Lancet Respir Med; 2020 Feb; 8(2):182-191. PubMed ID: 31810865
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
26. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.
Nobre V; Harbarth S; Graf JD; Rohner P; Pugin J
Am J Respir Crit Care Med; 2008 Mar; 177(5):498-505. PubMed ID: 18096708
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
[TBL] [Abstract][Full Text] [Related]
28. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
[TBL] [Abstract][Full Text] [Related]
29. Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial.
Kyriazopoulou E; Liaskou-Antoniou L; Adamis G; Panagaki A; Melachroinopoulos N; Drakou E; Marousis K; Chrysos G; Spyrou A; Alexiou N; Symbardi S; Alexiou Z; Lagou S; Kolonia V; Gkavogianni T; Kyprianou M; Anagnostopoulos I; Poulakou G; Lada M; Makina A; Roulia E; Koupetori M; Apostolopoulos V; Petrou D; Nitsotolis T; Antoniadou A; Giamarellos-Bourboulis EJ
Am J Respir Crit Care Med; 2021 Jan; 203(2):202-210. PubMed ID: 32757963
[No Abstract] [Full Text] [Related]
30. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock.
Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M
BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
[TBL] [Abstract][Full Text] [Related]
32. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial.
Euden J; Thomas-Jones E; Aston S; Brookes-Howell L; Carman J; Carrol E; Gilbert S; Howard P; Hood K; Inada-Kim M; Llewelyn M; McGill F; Milosevic S; Niessen LW; Nsutebu E; Pallmann P; Schmidt P; Taylor-Robinson D; Welters I; Todd S; French N;
BMJ Open; 2022 Jun; 12(6):e063424. PubMed ID: 35697438
[TBL] [Abstract][Full Text] [Related]
33. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.
Christ-Crain M; Jaccard-Stolz D; Bingisser R; Gencay MM; Huber PR; Tamm M; Müller B
Lancet; 2004 Feb; 363(9409):600-7. PubMed ID: 14987884
[TBL] [Abstract][Full Text] [Related]
34. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates.
Rao SC; Ahmed M; Hagan R
Cochrane Database Syst Rev; 2006 Jan; (1):CD005091. PubMed ID: 16437518
[TBL] [Abstract][Full Text] [Related]
35. Changes in serum procalcitonin and C-reactive protein following antimicrobial therapy as a guide to antibiotic duration in the critically ill: a prospective evaluation.
Venkatesh B; Kennedy P; Kruger PS; Looke D; Jones M; Hall J; Barruel GR
Anaesth Intensive Care; 2009 Jan; 37(1):20-6. PubMed ID: 19157341
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial.
Ibrahim LF; Hopper SM; Orsini F; Daley AJ; Babl FE; Bryant PA
Lancet Infect Dis; 2019 May; 19(5):477-486. PubMed ID: 30853250
[TBL] [Abstract][Full Text] [Related]
37. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial.
Mo Y; Booraphun S; Li AY; Domthong P; Kayastha G; Lau YH; Chetchotisakd P; Limmathurotsakul D; Tambyah PA; Cooper BS;
Lancet Respir Med; 2024 May; 12(5):399-408. PubMed ID: 38272050
[TBL] [Abstract][Full Text] [Related]
38. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
[TBL] [Abstract][Full Text] [Related]
39. Procalcitonin-guided antibiotic therapy in patients with fever in a general emergency department population: a multicentre non-inferiority randomized clinical trial (HiTEMP study).
van der Does Y; Limper M; Jie KE; Schuit SCE; Jansen H; Pernot N; van Rosmalen J; Poley MJ; Ramakers C; Patka P; van Gorp ECM; Rood PPM
Clin Microbiol Infect; 2018 Dec; 24(12):1282-1289. PubMed ID: 29870855
[TBL] [Abstract][Full Text] [Related]
40. Simplified antibiotic regimens for treatment of clinical severe infection in the outpatient setting when referral is not possible for young infants in Pakistan (Simplified Antibiotic Therapy Trial [SATT]): a randomised, open-label, equivalence trial.
Mir F; Nisar I; Tikmani SS; Baloch B; Shakoor S; Jehan F; Ahmed I; Cousens S; Zaidi AK
Lancet Glob Health; 2017 Feb; 5(2):e177-e185. PubMed ID: 27988146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
